Pregnancy

Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity

BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming...

Fertility Sensor Market to Reach USD 2.80 Billion by 2033, Driven by At-Home Reproductive Monitoring Surge and Connected Health Integration – Verified Market Research®

The Global Fertility Sensor Market fueled by rising consumer demand for sensor-enabled ovulation tracking and conception planning tools. Wearable fertility...

error: Content is protected !!